RETINAI Discovery®

Enabling the right decisions in clinics, research & pharma
Analytics
Vendor-neutral & multi-modal
Teleophthalmology
Collaborative research
Data Management
Data harmonization, aggregation, collection and advanced data processing
Data Connectivity
Single, unified repository of datawhich is secure, cloud-based withreal-time data access from anywhere and at anytime
AI Enrichment
In-house built AI models to extract automatic insights on patient diseases and outcomes
I am a:
and I’m interested in:
FIND OUT MORE
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Discovery® Products
DISCOVERY UNITY - FOR PHARMA & LIFE SCIENCES
RetinAI Discovery® UNITY is designed to improve the healthcare decision process in Ophthalmology. It is one platform for unification and structuring of data in a single ecosystem.  

By unlocking the power of data, Discovery UNITY helps pharmaceutical and life sciences build unparalleled disease understanding to help guide and accelerate research and development for better patient care.
Learn More
DISCOVERY for CLINICAL STUDIES - FOR PHARMA & LIFE SCIENCES, CROs, RESEARCHERS
RetinAI Discovery® for Clinical Studies uses a decentralized approach for multi-modal image and data collection and management, empowering decision makers with innovative AI tools for endpoint analysis and supporting patient assessment and enrollment. The certified platform accelerates clinical studies by effectively managing data at scale from multiple vendors and data sources.
Learn More
DISCOVERY CORE - FOR PHYSICIANS & RESEARCHERS
RetinAI Discovery® CORE™ is a medical and imaging data management platform designed to share data in a privacy-preserving, secure manner across collaborators. Data is maintained in a cloud-based, digitized environment for real-time visibility to insights being generated and knowledge growing. Teleophthalmology, collaborative data analysis and research and individuals’ training are enhanced through Discovery® CORE™.
Learn More

*Disclaimer

RetinAI Discovery® and the AI models are CE-Marked medical devices according to the Medical Devices Directive 93/42/EEC.
RetinAI Discovery® is a 510(k) FDA Cleared medical device in US.
RetinAI Discovery® and Retinai® are both trademarks of RetinAI Medical AG.

Discovery and AI Models are CE-Marked medical devices since April 2020 & December 2020 respectively.